Method of screening disease depressant gene

Details Method of screening disease depressant gene Method of screening disease depressant gene

2000-09-14

2008-08-12

Vogel, Nancy (Department: 1636)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S455000

Reexamination Certificate

active

07410757

ABSTRACT:
The present invention provides methods for screening and testing disorder suppressor genes and disorder suppressor polypeptides. By screening the cDNA expression library incorporated with nucleic acids derived from an organism suffering from a disorder that accompanies cell death, genes having suppressive effects on the disorder symptoms were successfully cloned. Furthermore, suppressive effects of the nucleic acid and polypeptide encoded by the nucleic acid on the disorder have been also examined. Screening of nucleic acids or polypeptides derived from an organism suffering from a disorder that accompanies cell death enables the efficient isolation and selection of suppressor genes of the disorder.

REFERENCES:
patent: 0 616 032 (1994-09-01), None
patent: 11-146743 (1999-06-01), None
patent: 11-146743 (1999-06-01), None
patent: WO 00/14204 (2000-03-01), None
patent: WO 00/14204 (2000-03-01), None
patent: WO 01/21787 (2001-03-01), None
patent: WO 01/21787 (2001-03-01), None
Giambarella et al. EMBO 16: 4897-4907, 1997.
Nordquist et al. J. Neurscience 8: 4780-4789, 1988.
Arriza et al. J. Neuroscience 12: 4045-4055, 1992.
Saille, C. et al. Transgenic Murine Cortical Neurons Expressing Human Bcl-2 Exhibit Increased Resistance to Amyloid Beta-Peptide Neurotoxicity, Neuroscience 92(4):1455-1463, 1999.
D'Adamio et al., “Functional cloning of genes involved in T-cell receptor-induced programmed cell death,”Seminars in Immunology, 9:17-23 (1997).
Guo et al., “Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function,”PNAS, 95:3227-3232 (1998).
Vito et al., “Interfering with Apoptosis: Ca2+ -Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3,”Science, 271:521-525 (1996).
Chiba et al., “Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo,”Neurobiology of Disease, 25(44): 10252-10261 (2005).

Affiliated with

Also associated with

Rating

Method of screening disease depressant gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of screening disease depressant gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening disease depressant gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4017298